On the 20th local time, WHO held a regular press conference on new coronary pneumonia.
Michael Ryan, WHO health emergency project leader, said that so far, hydroxychloroquine or chloroquine has not been found to be effective in treating or preventing new coronary pneumonia. In fact, on the contrary, many agencies have issued warnings about the potential side effects of the drug The country has restricted the drug to only be used in clinical trials of new coronary pneumonia, or to take it under the supervision of a doctor in a hospital, because a series of potential side effects have occurred or may occur.
Michael Ryan emphasized that each national authority should weigh and evaluate the use of the drug with regard to relevant evidence. Currently, WHO has used hydroxychloroquine or chloroquine in some clinical trials of the "Unity Trial" project. WHO recommends that it Use is limited to such tests.
Earlier, US President Trump said he was taking hydroxychloroquine. (Headquarters reporter Zhu He)